We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
-0.43%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$18.6B
AUM Growth
-$1.59B
Cap. Flow
-$881M
Cap. Flow %
-4.75%
Top 10 Hldgs %
25.83%
Holding
430
New
84
Increased
94
Reduced
203
Closed
27

Top Buys

Rank Stock Value
1
AFRM icon
Affirm
AFRM
+$241M
2
TWLO icon
Twilio
TWLO
+$60M
3
XYZ
Block Inc
XYZ
+$50.5M
4
BBIO icon
BridgeBio Pharma
BBIO
+$50M
5
SOFI icon
SoFi Technologies
SOFI
+$45.9M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$398M
2
ROKU icon
Roku
ROKU
+$137M
3
MTCH icon
Match Group
MTCH
+$117M
4
GS icon
Goldman Sachs
GS
+$107M
5
ENPH icon
Enphase Energy
ENPH
+$96M

Sector Composition

Rank Sector Weight
1 Technology 26.52%
2 Healthcare 23.41%
3 Consumer Discretionary 18.52%
4 Communication Services 12.03%
5 Miscellaneous 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBN icon
226
ICICI Bank
IBN
$102B
$4.33M 0.02%
270,086
-12,432
-4% -$203K
ANAC.U
227
DELISTED
Arctos NorthStar Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
ANAC.U
$4.22M 0.02%
+422,696
New +$4.27M
DDOG icon
228
Datadog
DDOG
$81.3B
$4.21M 0.02%
50,507
-205,426
-80% -$19.8M
AFYA icon
229
Afya
AFYA
$1.21B
$4.16M 0.02%
223,895
-21,206
-9% -$479K
AGI icon
230
Alamos Gold
AGI
$14.6B
$4.04M 0.02%
517,544
-4,049
-0.8% -$32.5K
ZS icon
231
Zscaler
ZS
$30.9B
$3.78M 0.02%
21,993
-89,747
-80% -$17.8M
OM icon
232
Outset Medical
OM
$58.6M
$3.71M 0.02%
4,550
+34
+0.8% +$26.2K
MGI
233
DELISTED
MoneyGram International, Inc. New
MGI
$3.68M 0.02%
+560,235
New +$4.1M
PROF
234
Profound Medical
PROF
$212M
$3.5M 0.02%
173,784
+40,368
+30% +$968K
SHLS icon
235
Shoals Technologies Group
SHLS
$1.21B
$3.38M 0.02%
+97,255
New +$3.45M
TWOU
236
DELISTED
2U Inc
TWOU
$3.33M 0.02%
2,907
+328
+13% +$416K
GH icon
237
Guardant Health
GH
$22.8B
$3.22M 0.02%
21,117
+12,873
+156% +$1.95M
BATRA icon
238
Atlanta Braves Holdings Series A
BATRA
$3.58B
$2.98M 0.02%
104,529
-17,272
-14% -$498K
WPM icon
239
Wheaton Precious Metals
WPM
$67B
$2.96M 0.02%
77,456
-581
-0.7% -$23.1K
DMTK
240
DELISTED
DermTech, Inc. Common Stock
DMTK
$2.84M 0.02%
+55,863
New +$2.92M
APA icon
241
APA Corp
APA
$16.4B
$2.75M 0.01%
153,685
-7,391
-5% -$135K
CLAS
242
DELISTED
Class Acceleration Corp.
CLAS
$2.74M 0.01%
+283,415
New +$2.75M
JPM icon
243
JPMorgan Chase
JPM
$923B
$2.58M 0.01%
16,934
+874
+5% +$126K
ILMN icon
244
Illumina
ILMN
$32.1B
$2.55M 0.01%
6,835
-548
-7% -$223K
EB
245
DELISTED
Eventbrite
EB
$2.47M 0.01%
111,506
+89,460
+406% +$1.8M
AUPH icon
246
Aurinia Pharmaceuticals
AUPH
$2.13B
$2.4M 0.01%
184,825
+4,575
+3% +$66.4K
HEI icon
247
HEICO Corp
HEI
$41.7B
$2.38M 0.01%
18,962
-1,077
-5% -$138K
LYFT icon
248
Lyft
LYFT
$5.92B
$2.36M 0.01%
37,301
-7,018
-16% -$392K
BCRX icon
249
BioCryst Pharmaceuticals
BCRX
$2.08B
$2.15M 0.01%
+211,407
New +$2.18M
RARE icon
250
Ultragenyx Pharmaceutical
RARE
$1.31B
$2.09M 0.01%
18,388
-4,896
-21% -$667K

Similar funds

Gilder Gagnon Howe & Co's Q1 2021 Portfolio in Review

As of Q1 2021, Gilder Gagnon Howe & Co held 430 positions worth $18.6B, down 7.9% from $20.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $881M in Q1 2021, closing 27 positions and reducing 203 holdings. Its most notable exit was Eidos Therapeutics, Inc. Common Stock, an estimated $43.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Affirm worth $175M.

  • Gilder Gagnon Howe & Co's largest Q1 2021 buy was Affirm: 2,479,834 shares worth $175M.
  • Gilder Gagnon Howe & Co added most to Twilio in Q1 2021, an estimated $60M increase.
  • Gilder Gagnon Howe & Co's biggest Q1 2021 reduction was Tesla, cutting an estimated $398M.
  • Gilder Gagnon Howe & Co fully exited Eidos Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $43.8M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 26% of its $18.6B portfolio in Q1 2021.
  • Gilder Gagnon Howe & Co opened 84 new positions and closed 27 in Q1 2021.
  • Gilder Gagnon Howe & Co's portfolio value fell 7.9% quarter-over-quarter to $18.6B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2021, filed 17 May 2021.